Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Oxybutynin for Diabetic Neuropathy
NCT03050827Phase 3Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- May 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybutynin in diabetic peripheral neuropathy (DPN), sponsored by Eastern Virginia Medical School. Started May 2014; status: completed.
02
Drugs
oxybutynin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT03050827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050827.